Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data

References

• Administration SAaMHSResults from the 2013 National Survey on Drug Use and Health: Mental Health Findings, NSDUH Series H-49, HHS Publication No (SMA) 14-4887Rockville, MD2013
   Google Scholar
• FerrariAJCharlsonFJNormanREThe epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010PLoS One201387e6963723922765
   PubMed Web of Science ®Google Scholar
• AndradeLCaraveo-AnduagaJJBerglundPThe epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) SurveysInt J Methods Psychiatr Res200312132112830306
   PubMed Web of Science ®Google Scholar
• GreenbergPEKesslerRCBirnbaumHGThe economic burden of depression in the United States: how did it change between 1990 and 2000?J Clin Psychiatry200364121465147514728109
   PubMed Web of Science ®Google Scholar
• KocsisJHGelenbergAJRothbaumBChronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatmentJ Affect Disord20081101556118272232
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationPractice Guidleine for the Treatment of Patients With Major Depressive DisorderThird edArlington, VAAmerican Psychiatric Association2010
   Google Scholar
• KoenigAMThaseMEFirst-line pharmacotherapies for depression-what is the best choicePol Arch Med Wewn20091197–847848619776688
   PubMed Web of Science ®Google Scholar
• RascatiKDrug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medicationsClin Ther19951747867908565041
   PubMed Web of Science ®Google Scholar
• PapakostasGISheltonRCSmithJFavaMAugmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysisJ Clin Psychiatry200768682683117592905
   PubMed Web of Science ®Google Scholar
• DiMatteoMRLepperHSCroghanTWDepression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherenceArch Intern Med2000160142101210710904452
   PubMed Web of Science ®Google Scholar
• WadeAGHäringJA review of the costs associated with depression and treatment noncompliance: the potential benefits of online supportInt Clin Psychopharmacol201025528829620715299
   PubMed Web of Science ®Google Scholar
• NantzELiu-SeifertHSkljarevskiVPredictors of premature discontinuation of treatment in multiple disease statesPatient Prefer Adherence200933119936143
   PubMed Web of Science ®Google Scholar
• RuheHGHuyserJSwinkelsJAScheneAHSwitching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic reviewJ Clin Psychiatry200667121836185517194261
   PubMed Web of Science ®Google Scholar
• SpinaETrifiròGCaraciFClinically significant drug interactions with newer antidepressantsCNS Drugs2012261396722171584
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders (DSM-5®)Arlington, VAAmerican Psychiatric Pub2013
   Google Scholar
• TrivediMHRushAJWisniewskiSREvaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practiceAmerican Journal of Psychiatry201416312840
   Web of Science ®Google Scholar
• QaseemASnowVDenbergTDForcieaMAOwensDKUsing second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of PhysiciansAnn Intern Med20081491072573319017591
   PubMed Web of Science ®Google Scholar
• MelfiCAChawlaAJCroghanTWHannaMPKennedySSredlKThe effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depressionArch Gen Psychiatry19985512112811329862557
   PubMed Web of Science ®Google Scholar
• RushAJTrivediMHWisniewskiSRAcute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D reportAm J Psychiatry2006163111905191717074942
   PubMed Web of Science ®Google Scholar
• NicholsALubaczewskiSLiangYMatschkeKBraleyGAn open-label evaluation of the effect of coadministering desvenlafaxine 100 mg on the pharmacokinetics of aripiprazole in healthy subjectsJ Bioequiv Availab20135253259
   Google Scholar
• KotzanJAMacleanRWadeWPrevalence and patterns of concomitant use of selective serotonin reuptake inhibitors and other antidepressants in a high-cost polypharmacy cohortClin Ther200224223724811911554
   PubMed Web of Science ®Google Scholar
• SheltonRCHollonSDWisniewskiSRFactors associated with concomitant psychotropic drug use in the treatment of major depression: a STAR* D ReportCNS Spectr2009140948749819890231
   PubMed Web of Science ®Google Scholar
• WangJLiuXMullinsCDTreatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseasesCurr Med Res Opin20112771303131321561393
   PubMed Web of Science ®Google Scholar
• MullinsCDShayaFTMengFWangJHarrisonDPersistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopramPharmacotherapy200525566066715899727
   PubMed Web of Science ®Google Scholar
• EreshefskyLSaragoussiDDespiégelNHansenKFrançoisCMamanKThe 6-month persistence on SSRIs and associated economic burdenJ Med Econ201013352753620701432
   PubMedGoogle Scholar
• LinEHVon KorffMKatonWThe role of the primary care physician in patients’ adherence to antidepressant therapyMed Care199533167747823648
   PubMed Web of Science ®Google Scholar
• SansoneRASansoneLAAntidepressant adherence: are patients taking their medications?Innov Clin Neurosci201295–6414622808448
   PubMedGoogle Scholar
• DeanLwebpage on the InternetComparing AntidepressantsPubMed Clinical Q&A2011 Available from: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0004912/Accessed August 18, 2016
   Google Scholar
• JiaYZhuHLeungS-WComparative efficacy of selective serotonin reuptake inhibitors (SSRI) in treating major depressive disorder: a protocol for network meta-analysis of randomised controlled trialsBMJ Open201666e010142
   Web of Science ®Google Scholar
• GartlehnerGThalerKHillSHansenRAHow should primary care doctors select which antidepressants to administer?Curr Psychiatry Rep201214436036922648236
   PubMed Web of Science ®Google Scholar
• AssayagJForgetAKettaniF-ZBeauchesneM-FMoisanJBlaisLThe impact of the type of insurance plan on adherence and persistence with antidepressants: a matched cohort studyCan J Psychiatry201358423323923547647
   PubMed Web of Science ®Google Scholar
• BarronJWahlPFisherMPlauschinatCEffect of prescription copayments on adherence and treatment failure with oral antidiabetic medicationsP T200833953255319750032
   PubMedGoogle Scholar
• ZengFPatelBAndrewsLFrech-TamasFRudolphAAdherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimensCurr Med Res Opin201026122877288721067459
   PubMed Web of Science ®Google Scholar